Dysregulation of MAD2L1 mediates increased tumor susceptibility,[11] rapid tumor progression,[36] and resistance to chemotherapy.[37] MAD2L1 expression and activity are regulated by multiple factors. Here, MAD2L1 is linked to neoplasm.